Epilepsy: The Next Generation Drugs (A Review)

α
Amit Kumar Shrivastava
Amit Kumar Shrivastava
σ
Amit K. Shrivastava
Amit K. Shrivastava
ρ
Manish Dhar Dwivedi
Manish Dhar Dwivedi
Ѡ
Gulzar Alam
Gulzar Alam

Send Message

To: Author

Epilepsy: The Next Generation Drugs (A Review)

Article Fingerprint

ReserarchID

PDDTM1W96D

Epilepsy: The Next Generation Drugs (A Review) Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

Seizures are common and are treated in all branches of medicine. Approximately 10% of the population will have one or more seizures during their lifetime. Seizures are symptoms that occur in acute illness, ie, provoked seizures, or in epilepsy, ie, unprovoked seizures. Antiepileptic drugs (AEDs) are pharmacologic agents used to reduce the frequency of epileptic seizures. “Antiepileptic” drug is a misnomer, because these drugs are effective as symptomatic treatment of seizures, i.e., the symptoms of epilepsy, not as treatment of epilepsy itself. Recent discoveries in molecular biology and genetics have elucidated a genetic basis for some epilepsy syndromes, which will lead to new treatments. This review include new AEDs viz; Ganaxolone, Eslicarbazepine acetate, Fluorofel-bamate, Huperzine A, Carisbamate (RWJ-333369), Brivaracetam (ucb 34714), 2-Deoxy-D-glucose, Retigabine, T2000 , T2007, Valrocemide, Tonabersat (SB-220453), YKP3089, Propyl isopropyl acetamide, JZP-4, ICA-105665, NAX-5055, Perampanel and Valpromide.

References

40 Cites in Article
  1. W Hauser,J Annegers,W Rocca (1996). Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota.
  2. Armin Haerer,Dallas Anderson,Bruce Schoenberg (1986). Prevalence and Clinical Features of Epilepsy in a Biracial United States Population.
  3. W Hauser,J Annegers,W Rocca (1996). Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota.
  4. W Hauser,John Annegers,Leonard Kurland (1991). Prevalence of Epilepsy in Rochester, Minnesota: 1940–1980.
  5. W Hauser,J Annegers,L Kurland (1993). Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.
  6. J Annegers,W Rocca,W Hauser (1996). Causes of epilepsy: contributions of the Rochester epidemiology project.
  7. Virinder Nohria,Earl Giller (2004). Ganaxolone.
  8. Richard Carter,Paul Wood,Scott Wieland,Jon Hawkinson,Delia Belelli,Jeremy Lambert,H White,Harold Wolf,Seid Mirsadeghi,S Tahir,Michael Bolger,Nancy Lan,Kelvin Gee (1997). Characterization of the Anticonvulsant Properties of Ganaxolone (CCD 1042; 3α-Hydroxy-3β-methyl-5α-pregnan-20-one), a Selective, High-Affinity, Steroid Modulator of the γ-Aminobutyric AcidA Receptor.
  9. M Le´skiewicz,B Budziszewska,L Jaworska-Feil,M Kubera,W Basta-Kaim Lason (2003). Inhibitory effect of some neuroactive steroids on cocaine-induced kindling in mice.
  10. M Rogawski,D Reddy (2004). Neurosteroids: endogenous modulators of seizure susceptibility.
  11. G Biagini,E Baldelli,D Longo,L Pradelli,I Zini,M Rogawski,M Avoli (2006). Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy.
  12. Jan Benes,António Parada,Anabela Figueiredo,Paula Alves,Ana Freitas,David Learmonth,Rodrigo Cunha,José Garrett,Patrício Soares-Da-Silva (1999). Anticonvulsant and Sodium Channel-Blocking Properties of Novel 10,11-Dihydro-5<i>H</i>-dibenz[<i>b</i>,<i>f</i>]azepine-5-carboxamide Derivatives.
  13. Ambrosio,Silva Araujo,I,Malva Soaresda-Silva,P Carvalho,A Carvalho,C (2000). Neurotoxic/ neuroprotective profile of carbamazepine, oxcarba-zepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024.
  14. Rodrigo Cunha,Joana Coelho,Ana Costenla,Luísa Lopes,António Parada,Alexandre De Mendonça,Ana Sebastião,J Ribeiro (2002). Effects of Carbamazepine and Novel 10,11‐Dihydro‐5<i>H</i>‐Dibenz[<i>b,f</i>]Azepine‐5‐Carboxamide Derivatives on Synaptic Transmission in Rat Hippocampal Slices.
  15. Luis Almeida,Patrício Soares-Da-Silva (2007). Eslicarbazepine Acetate (BIA 2-093).
  16. Jarrod Ward,Vittorio Caprio (2006). A radical mediated approach to the core structure of huperzine A.
  17. M Bialer,S Johannessen,H Kupferberg,Levy Perucca,E Tomson,T (2004). Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).
  18. Wallis Panizzon,K Niquet,J Masaratis,L Baldwin,R Wasterlain,C (2000). Neuroprotective effects of the anticonvulsant, fluorofelbamate.
  19. H White,S Schachter,D Lee,J Xiaoshen,D Eisenberg (2005). Anticonvulsant activity of Huperzine A, an alkaloid extract of Chinese club moss (Huperzia serrata).
  20. Andrea Zangara (2003). The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.
  21. H White,A Srivastava,B Klein (2006). The novel investigational neuromodulator RWJ-333369 displays a broad-spectrum anticonvulsant profile in rodent seizure and epilepsy models.
  22. Heidi Grabenstatter,F Dudek (2008). A new potential AED, carisbamate, substantially reduces spontaneous motor seizures in rats with kainate‐induced epilepsy.
  23. Isabelle Niespodziany,Jean‐michel Rigo,Gustave Moonen,Alain Matagne,Henrik Klitgaard,Christian Wolff (2009). Brivaracetam does not modulate ionotropic channels activated by glutamate, γ‐aminobutyric acid, and glycine in hippocampal neurons.
  24. R Kaminski,A Matagne,K Leclercq,M Gillard,P Michel,B Kenda,P Talaga,H Klitgaard (2008). SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy.
  25. A Matagne,D‐g Margineanu,B Kenda,P Michel,H Klitgaard (2008). Anti‐convulsive and anti‐epileptic properties of brivaracetam (ucb 34714), a high‐affinity ligand for the synaptic vesicle protein, SV2A.
  26. J Berwick,D Johnston,M Jones,J Martindale,C Martin,A Kennerley,P Redgrave,J Mayhew (2008). Fine Detail of Neurovascular Coupling Revealed by Spatiotemporal Analysis of the Hemodynamic Response to Single Whisker Stimulation in Rat Barrel Cortex.
  27. Chris Rundfeldt,Rainer Netzer (2000). The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.
  28. Ofer Spiegelstein,Boris Yagen,Meir Bialer (1999). Structure‐Pharmacokinetic‐Pharmacodynamic Relationships of yV‐Alkyl Derivatives of the New Antiepileptic Drug Valproyl Glycinamide.
  29. M Bialer,S Johannessen,H Kupferberg,R Levy,P Loiseau,E Perucca (2001). Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V).
  30. M Bialer,S Johannessen,H Kupferberg,Levy Loiseau,P Perucca,E (2002). Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).
  31. M Bialer,S Johannessen,H Kupferberg,Levy Perucca,E Tomson,T (2004). Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).
  32. Andrew Parsons,Sharon Bingham,Pravin Raval,Simon Read,Mervyn Thompson,Neil Upton (2001). Tonabersat (SB‐220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve‐induced neurovascular reflexes.
  33. Meir Bialer,Svein Johannessen,René Levy,Emilio Perucca,Torbjörn Tomson,H White (2010). Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X).
  34. M Bialer (1991). Clinical pharmacology of valpromide.
  35. Meir Bialer,Svein Johannessen,Harvey Kupferberg,René Levy,Emilio Perucca,Torbjörn Tomson (2007). Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII).
  36. A Funk,R Ricci,Anderson,Arana De Colle,C,Wang,George Single doses of JZP-4 decrease cortical excitability. A transcranial magnetic stimulation study.
  37. Binnie,Kasteleijn-Nolst Trenité,D,De Korte,R (1986). Photosensitivity as a model for acute antiepileptic drug studies.
  38. H White,Erika Scholl,Brian Klein,Sean Flynn,Timothy Pruess,Brad Green,Liuyin Zhang,Grzegorz Bulaj (2009). Developing Novel Antiepileptic Drugs: Characterization of NAX 5055, a Systemically-Active Galanin Analog, in Epilepsy Models.
  39. Y Hashizume,T Hanada,A Ogasawara,M Ueno,Y Nishizawa (2008). Anticonvulsant activity of perampanel, a selective AMPA receptor antagonist, in rodent models of epileptic seizure.
  40. G Shaltiel,M Shirley,Ora Belmaker,R Agam,G (2007). Effect of valproate derivatives on human brain myo-inositol-1-phosphate (MIP) synthase activity and amphetamine-induced rearing.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Amit Kumar Shrivastava. 2014. \u201cEpilepsy: The Next Generation Drugs (A Review)\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 14 (GJMR Volume 14 Issue B4): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Version of record

v1.2

Issue date

September 4, 2014

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 4488
Total Downloads: 2367
2026 Trends
Related Research

Published Article

Seizures are common and are treated in all branches of medicine. Approximately 10% of the population will have one or more seizures during their lifetime. Seizures are symptoms that occur in acute illness, ie, provoked seizures, or in epilepsy, ie, unprovoked seizures. Antiepileptic drugs (AEDs) are pharmacologic agents used to reduce the frequency of epileptic seizures. “Antiepileptic” drug is a misnomer, because these drugs are effective as symptomatic treatment of seizures, i.e., the symptoms of epilepsy, not as treatment of epilepsy itself. Recent discoveries in molecular biology and genetics have elucidated a genetic basis for some epilepsy syndromes, which will lead to new treatments. This review include new AEDs viz; Ganaxolone, Eslicarbazepine acetate, Fluorofel-bamate, Huperzine A, Carisbamate (RWJ-333369), Brivaracetam (ucb 34714), 2-Deoxy-D-glucose, Retigabine, T2000 , T2007, Valrocemide, Tonabersat (SB-220453), YKP3089, Propyl isopropyl acetamide, JZP-4, ICA-105665, NAX-5055, Perampanel and Valpromide.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Epilepsy: The Next Generation Drugs (A Review)

Amit K. Shrivastava
Amit K. Shrivastava
Manish Dhar Dwivedi
Manish Dhar Dwivedi
Gulzar Alam
Gulzar Alam

Research Journals